Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for IBALIZUMAB
- 10E8.4/iMab Bispecific Antibody and VRC07-523LS Monoclonal Antibody in HIV-infected Adults
- Changes in Immunologic Parameters Following the Addition of Fostemsavir in Virologically Suppressed Immunologic Non-responders Living With HIV-the RECOVER Study
- Ibalizumab Plus Optimized Background Regimen in Treatment-Experienced Patients With Multi-Drug Resistant HIV-1
- Ibalizumab Plus Optimized Background Regimen in Patient With Multi-Drug Resistant HIV
- Compassionate Use of Ibalizumab for the Treatment of HIV Infection
- Investigator-Sponsored Protocol - Continued Use of Ibalizumab
- Dose-Response Study of Ibalizumab (Monoclonal Antibody) Plus Optimized Background Regimen in Patients With HIV-1
Clinical trials list
click for details